课题基金 / 基金详情

Elucidating the role of cancer stem cells in the metastatic progression of pancreatic neuroendocrine tumors

Elucidating the role of cancer stem cells in the metastatic progression of pancreatic neuroendocrine tumors
阐明癌症干细胞在胰腺神经内分泌肿瘤转移进展中的作用
批准号:
21K15498
负责人:
カポダッノ イレニア
金额:
$2.08万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Early-Career Scientists
财政年份:
2021
资助国家:
日本
项目状态:
已结题
起止时间:
2021-04-01 至 2022-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
胰腺神经内分泌肿瘤(PanNETs)是一种高度异质性的肿瘤,因此开发一种治愈性的治疗方法已被证明具有挑战性。基因组分析显示,这些肿瘤通常没有典型癌症相关基因(如p53)的突变。尽管它们携带着独特的pannet相关基因突变,比如MEN-1。然而,关于肿瘤发生的机制,特别是这些肿瘤的异质性,还缺乏很多知识。在这个项目中,我使用多模式方法分析了肿瘤间和肿瘤内的异质性,并确定了PanNET肿瘤发生的一些关键节点。具体来说,我已经证明当men1突变发生时,Notch通路和p53在PanNET中相互交织,促进肿瘤发生。最有趣的是,我发现胰岛素瘤相关-1 (INSM1)是PanNET早期发病中MEN1缺失和p53为野生型时增殖的关键标志物。这些数据表明,PanNETs中特定的基因组改变影响其肿瘤发生。考虑到目前缺乏基于基因组异常对所有PanNET患者进行分层的系统,这些发现可能因此为改善未来的临床决策和改善PanNET患者的预后提供了机会。
英文摘要
Pancreatic neuroendocrine tumors (PanNETs) are highly heterogeneous tumors and for this reason developing a curative treatment has been proven challenging. Genomic analysis revealed that these tumors often do not harbor mutations in typical cancer-related genes such as p53. Although they harbor mutation in unique PanNET-related genes such as MEN-1. Still, much knowledge is missing on the mechanisms of tumorigenesis and specifically on the heterogeneity of these tumors. Using a multimodal approach in this project I have analysed both the inter- and intra- tumor heterogeneity and I have identified some of the crucial nodes of PanNET tumorogenesis. Specifically, I have demonstrated that the Notch pathway and p53 intertwine in PanNET to promote tumorigenesis when MEN-1 mutations occur. Most interestingly, I have identified insulinoma associated-1 (INSM1) as a key marker of proliferation in PanNET early onset when MEN1 is lost and p53 is wildtype.These data suggest that specific genomic alterations in PanNETs influence their tumorigenesis. Considering the current lack of a system to stratify all PanNET patients based on their genomic abnormalities, these findings may thereby provide an opportunity to improve future clinical decisions and improve the prognosis of PanNET patients.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
MEN1, p53 and Notch pathways regulates proliferation during formation of primary pancreatic neuroendocrinetumors
MEN1、p53 和 Notch 通路在原发性胰腺神经内分泌肿瘤形成过程中调节增殖
DOI: --
发表时间: 2022
期刊:
影响因子: --
作者: [Capodanno Ylenia, Chen Yu, Schrader Joerg, Tomosugi M, Sumi S, Yokoyama A, Ohki Rieko, Ylenia Capodanno]
通讯作者: Ylenia Capodanno
国内基金
海外基金
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
  • 批准号:
    2026JJ82384
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    颜志鹏
  • 依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
  • 批准号:
    JCZRQNB202600696
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究